Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neural Therapeutics Inc. ( (TSE:NURL) ) has shared an update.
Neural Therapeutics Inc. has commenced trading on the Frankfurt Stock Exchange, aiming to access a broader international investor base and enhance liquidity. This move is expected to support the company’s growth strategy, including the proposed acquisition of Hanf.com, by increasing brand awareness and retail sales in Germany, thus strengthening its market position.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is a leader in ethnobotanical drug discovery, focusing on developing therapeutic drugs for mental illnesses related to substance use disorders, such as alcohol and opioid dependence. The company employs an innovative approach using sub-hallucinogenic doses of mescaline extract to enhance safety and scalability while maintaining therapeutic efficacy.
Average Trading Volume: 117,987
Find detailed analytics on NURL stock on TipRanks’ Stock Analysis page.